Related Experiment Videos
Duration of prophylactic effect of statolon against mengovirus in mice
Abstract:
Intraperitoneal injection of statolon into mice is known to exert a protective effect against a subsequent infection with a variety of viruses owing to stimulation of production of interferon. To study the duration of such protection, groups of mice were treated with 350 mug of statolon at 69, 55, 41, 27, 13, 6, or 1 day prior to a challenge with mengovirus. Other groups were treated with 760 mug at 1 to 6 days before challenge. Ten days after inoculation with the virus, LD(50) determinations were made for each group. Mice which received statolon 1 to 5 days before infection were significantly more resistant to the virus than nontreated controls; no protection could be demonstrated in the other groups.
Insights
Statolon administration induces interferon production, offering protection against viral infections. This study found that statolon provided significant protection against mengovirus when administered 1 to 5 days before infection in mice.
Area of Science:
- Immunology
- Virology
- Pharmacology
Background:
- Statolon, an interferon inducer, confers protection against viral infections.
- The duration of statolon-induced protection requires further investigation.
Purpose of the Study:
- To determine the optimal timing for statolon administration to confer protection against mengovirus infection.
- To evaluate the duration of antiviral protection induced by statolon.
Main Methods:
- Mice were injected intraperitoneally with statolon at varying time points (1 to 69 days) before mengovirus challenge.
- Lethal dose 50 (LD50) determinations were performed 10 days post-infection to assess protection levels.
- Different doses of statolon (350 µg and 760 µg) were administered.
Main Results:
- Statolon administration 1 to 5 days prior to mengovirus challenge significantly increased mouse survival rates.
- No significant protective effect was observed when statolon was administered more than 5 days before or on the day of infection.
- Higher doses of statolon did not extend the window of protection.
Conclusions:
- Statolon-induced antiviral protection is transient, with an optimal window of 1 to 5 days before viral challenge.
- The timing of statolon administration is critical for effective protection against mengovirus infection.
- Further research could explore mechanisms underlying the limited duration of statolon's protective effect.